Document is current
Any future updates will be listed below
-
Authors
Frieder, Ariela
Fersh, Madeleine
Hainline, Rachel
Deligiannidis, Kristina M. https://orcid.org/0000-0001-7439-2236
-
Funding
Funding for this research was provided by:
National Institute of Mental Health (5K23MH097794)
- License Information
-
More Information
Article History
First Online: 21 February 2019
Compliance with Ethical Standards
:
: This article was supported by a National Institutes of Health Grant (No. 5K23MH097794). Kristina M. Deligiannidis currently receives royalties from an National Institutes of Health Employee Invention.
: Kristina M. Deligiannidis has received research grant support as a site for the clinical trials of brexanolone and SAGE-217 and serves as a consultant for Sage Therapeutics. Ariela Frieder, Madeleine Fersh, and Rachel Hainline have no conflicts of interest that are directly relevant to the contents of this article. The views expressed in this article are those of the authors and do not necessarily reflect the position of the National Institutes of Health.
